Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Nitroglycerin
Drug ID BADD_D01579
Description Nitroglycerin is a vasodilator drug used for the treatment of chest pain and high blood pressure.[T628,L4429] It was first approved in 2000 and is currently marketed by Pfizer, and other companies, depending on the dosage form.[T628,L4894] Nitroglycerin is available in various forms, including a spray form, sublingual tablet form, intravenous form, extended-release tablet form, and transdermal form. A less commonly known fact is that in addition to treating angina, nitroglycerin is also used in an ointment to treat the pain that accompanies anal fissures. The rectal ointment form of nitroglycerin was approved by the FDA in 1955.[L7096]
Indications and Usage Nitroglycerin is indicated for various purposes.[L4894] It is indicated to prevent and treat angina or chest pain due to cardiovascular disease, as well as to treat peri-operative hypertension or induce intra-operative hypotension.[L4429,L7099] It is also indicated to treat acute heart failure in patients with myocardial infarction.[L7099] In the ointment form, nitroglycerin is indicated to treat pain caused by anal fissures.[L7096] The transdermal form is applied directly to the skin to prevent acute anginal attacks.[L7141] The intravenous form is used off-label in emergency settings and is commonly used to treat acute coronary spasm caused by cocaine, hypertensive emergencies, as well as acute congestive heart failure exacerbations.[T628] Some other off-label uses of nitroglycerin include management of variceal hemorrhage[A180280], management of esophageal spasticity[A180283], and induction of uterine relaxation.[A180277]
Marketing Status approved; investigational
ATC Code C05AE01; C01DA02
DrugBank ID DB00727
KEGG ID D00515
MeSH ID D005996
PubChem ID 4510
TTD Drug ID D07YDE
NDC Product Code 47781-457; 47781-458; 50742-513; 59762-3304; 63629-8830; 0378-9104; 0378-9116; 68428-407; 70710-1019; 70771-1718; 70771-1719; 43598-895; 45802-210; 49483-221; 50090-4874; 52584-418; 0338-1047; 68428-100; 71205-482; 71872-7010; 28595-120; 51662-1351; 51662-1386; 0404-9928; 68071-2260; 68071-2941; 68462-640; 70518-0545; 59762-0489; 0338-1051; 63629-8829; 68428-050; 70710-1018; 72888-138; 43598-435; 43598-436; 47781-456; 49483-223; 50742-518; 51662-1244; 52584-810; 60429-839; 0404-9929; 69339-173; 71872-7201; 72888-139; 43598-893; 50090-0332; 0220-2291; 50742-516; 60429-840; 60429-841; 68462-638; 72888-140; 0071-0417; 0071-0418; 43598-896; 58914-301; 63187-884; 0378-9112; 70771-1717; 71205-225; 0071-0419; 50090-3266; 50742-514; 50742-515; 0338-1049; 63629-8828; 69339-174; 70710-1020; 71872-7300; 0220-2283; 51662-1282; 51662-1340; 64117-543; 68462-639; 69339-175; 0517-4810; 28595-550; 43598-437; 43598-894; 49483-222; 50742-517; 0378-9102; 71872-7033; 0281-0326; 59762-4921
UNII G59M7S0WS3
Synonyms Nitroglycerin | Glyceryl Trinitrate | Trinitrate, Glyceryl | Nitrolan | Nitrospan | Nitrostat | Perlinganit | Nitrong | Susadrin | Sustac | Sustak | Sustonit | Transderm Nitro | Nitroglyn | Trinitrin | Trinitrolong | Anginine | Dynamite | Gilustenon | Nitrangin | Nitro-Bid | Nitro Bid | NitroBid | Nitro-Dur | Nitro Dur | NitroDur | Nitrocard | Nitroderm | Nitroderm TTS | Nitrol | Tridil
Chemical Information
Molecular Formula C3H5N3O9
CAS Registry Number 55-63-0
SMILES C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.0030.000194%
Acute myocardial infarction02.02.02.001; 24.04.04.0010.000290%-
Acute respiratory distress syndrome10.02.01.067; 22.01.03.001; 24.03.02.034--
Agitation17.02.05.012; 19.06.02.001--
Amaurosis fugax06.02.10.002; 17.08.04.002; 24.04.06.0060.000065%-
Anaphylactic reaction10.01.07.001; 24.06.03.0060.000097%
Anaphylactic shock10.01.07.002; 24.06.02.004---
Anaphylactoid reaction10.01.07.003; 24.06.03.007---
Angina pectoris02.02.02.002; 24.04.04.0020.000465%
Angina unstable02.02.02.004; 24.04.04.004---
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001---
Angle closure glaucoma06.03.01.0010.000065%-
Aortic aneurysm24.02.03.0010.000065%-
Application site dermatitis08.02.01.018; 12.07.01.018; 23.03.04.014---
Application site erythema08.02.01.001; 12.07.01.001; 23.03.06.0050.000548%-
Application site irritation08.02.01.003; 12.07.01.0030.000548%-
Application site oedema08.02.01.020; 12.07.01.020---
Application site pain08.02.01.004; 12.07.01.0040.000658%-
Application site pruritus08.02.01.005; 12.07.01.005; 23.03.12.0040.000361%-
Application site rash08.02.01.016; 12.07.01.016; 23.03.13.0080.000787%-
Application site reaction08.02.01.006; 12.07.01.0060.000361%-
Arrhythmia02.03.02.0010.000097%-
Arteriospasm coronary02.02.02.005; 12.02.01.031; 24.04.04.0050.000129%-
Asthenia08.01.01.001---
Asthma10.01.03.010; 22.03.01.002---
Atrial fibrillation02.03.03.002--
Atrioventricular block02.03.01.002---
Atrioventricular block complete02.03.01.0030.000323%
Blister12.01.06.002; 23.03.01.001---
The 1th Page    1 2 3 4 5    Next   Last    Total 8 Pages